Since April, a team of researchers at the Oxford Jenner Institute have been gradually coming closer to developing a highly sought-after vaccine for COVID-19, AZD1222 (formerly ChAdOx1), with Business Secretary Alok Sharma stating that “the UK continues to lead the global response to find a vaccine”.
The University of Oxford announced today their agreement with AstraZeneca, a UK-based global biopharmaceutical company, to develop, manufacture and potentially distribute at a large scale the COVID-19 vaccine which is currently being worked on and trialled by the University. The partnership has been solidified now, with finer details and terms to be finalised in the Read More…
“This is by far the largest trial in the world,” said Peter Horby who is leading the trial and is professor of emerging infectious diseases and global health at Oxford University.
An Oxford based trial is aiming to test the effect of current drugs in treating Covid-19, and has recruited over 5000 patients in 165 NHS hospitals around the UK.
New Oxford research led by Professor Gupta and Dr Lourenco from the Department of Zoology stresses the urgent need for antibody blood (serological) tests. These could determine what proportion of the population has already been infected, and therefore has immunity, The Blue reports.
Sir Peter Ratcliffe and William Kaelin are two of the three current Nobel Prize Winners for Physiology or Medicine (2019). At the Oxford Union, we discussed their research on an oxygen-sensing mechanism in the cell and the journey that led them to this discovery.